Bio-Rad Laboratories, Inc. 13F holders
Of the 44 funds followed here, 7 reported a position in Bio-Rad Laboratories, Inc. in a 13F for the quarter ended 30 June 2026. The largest: Capital Research Global Investors, 443,483 shares worth $130.2 million, 0.0% of its reported book. Sold out: Southeastern Asset Management, Bridgewater Associates.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Capital Research Global Investors | 443,483 | $130.2 million | 0.0% | +57,904 | added | 30 June 2026 | 13F |
| Geode Capital Management | 347,575 | $102.1 million | 0.0% | -17,107 | trimmed | 30 June 2026 | 13F |
| Norges Bank | 111,580 | $32.8 million | 0.0% | held | 30 June 2026 | 13F | |
| Citadel Advisors | 63,919 | $18.8 million | 0.0% | -86,350 | trimmed | 30 June 2026 | 13F |
| Millennium Management | 59,895 | $17.6 million | 0.0% | +55,801 | added | 30 June 2026 | 13F |
| Two Sigma Investments | 10,320 | $3.0 million | 0.0% | -668 | trimmed | 30 June 2026 | 13F |
| FMR LLC | 4,305 | $1.3 million | 0.0% | +107 | added | 30 June 2026 | 13F |
| Southeastern Asset Management | 0 | $0 | 0.0% | -162,804 | exited | 30 June 2026 | 13F |
| Bridgewater Associates | 0 | $0 | 0.0% | -1,684 | exited | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 26 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 17 October 2025 | 13G/A | BlackRock, Inc. and 1 other | 1.6 million | 7.4% | 30 September 2025 | passive, institutional (13d-1(b)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short.Fails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 14 September 2026 | 400 | $369.32 | SEC |
| 10 September 2026 | 2,061 | $376.97 | SEC |
| 8 September 2026 | 3 | $386.11 | SEC |
| 3 September 2026 | 4,193 | $388.51 | SEC |
| 25 August 2026 | 17,170 | $381.76 | SEC |
| 18 August 2026 | 13,658 | $355.23 | SEC |
| 11 August 2026 | 102 | $354.54 | SEC |
| 5 August 2026 | 6,024 | $332.88 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read more
Largest in the window: 17,170 on 25 August 2026. A fail is an operational fact about settlement, not a position.Source
Each fund's 13F-HR on EDGAR, linked per row; positions matched to BIO by CUSIP from the SEC's own fails-to-deliver files; Schedule 13D and 13G from the company's own filing index, each read to confirm the company is the issuer named.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.